Matches in Nanopublications for { ?s ?p "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP845368.RAmEquMHRejMM_x3iQbySFuYHH3sD8vHQlUvXOZ0ld8vs130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845368.RAmEquMHRejMM_x3iQbySFuYHH3sD8vHQlUvXOZ0ld8vs130_provenance.
- NP560809.RALkrjgRfyhWNSQuQ3-FFAKUhsaMA6QfDNe7iskUehFIE130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560809.RALkrjgRfyhWNSQuQ3-FFAKUhsaMA6QfDNe7iskUehFIE130_provenance.
- assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP649903.RABPuCPFV_ucU0zI8UiMQIHy_GFgmK85LSB3JaOnz_0yI130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649903.RABPuCPFV_ucU0zI8UiMQIHy_GFgmK85LSB3JaOnz_0yI130_provenance.
- NP474268.RA46bfIm-r2F0QIj73i5ywlekyTff62OTMeN0sIgaudKQ130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474268.RA46bfIm-r2F0QIj73i5ywlekyTff62OTMeN0sIgaudKQ130_provenance.
- NP474300.RA4c5YxnsgsiUvXdKsUzfCknqiikxAErPaTAq3eMqDoTI130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474300.RA4c5YxnsgsiUvXdKsUzfCknqiikxAErPaTAq3eMqDoTI130_provenance.
- NP649904.RAzPN1BI-QiBeE7QEV66gd9Ec7sPuDJXmyIU-Qle4bLl4130_assertion description "[ICSBP-deficient mice develop a myeloproliferative disorder characterized by cytokine hypersensitivity and apoptosis resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649904.RAzPN1BI-QiBeE7QEV66gd9Ec7sPuDJXmyIU-Qle4bLl4130_provenance.